In CML, it has been found (Hermann et al., 2012b) that CD34+CD38-CD123+ cells expressed significantly higher levels of CD33 compared to normal CD34+CD38- stem cells. Here, CD38 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.